Targacept Inc. (TRGT) Stock Quote

Stock Web

Detailed Quote for Targacept Inc. (TRGT)

close 52 Week Information

52 Week High

May 13,2010

Close: 25.00

52 Week Low

September 02,2009

Close: 14.16

Today

5d

1m

3m

1y

more

Last Price
21.21

Change $
0.03

Change %
0.14%

Tick

Bid
21.30

Bid Size
100

Ask
21.35

Ask Size
300

Open
21.34

High
21.42

Low
20.85

Prev Close
21.24

Last Trade
10:23

Volume
8.73 k

52 Wk Hi
25.00

52 Wk Low
14.16

Market Cap
607 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
28,618,412

EPS (TTM)
-0.61

PE Ratio
N/A

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for Targacept Inc. (TRGT)

Sector News | Topic News

News for TRGT

Wed, Sep 01, 2010

12:16 PM

Alzheimer's Therapeutics Reviewed by NeuroInvestment - Marketwire

Wed, Aug 04, 2010

4:05 PM

Targacept Reports Second Quarter 2010 Financial Results - Business Wire

Tue, Aug 03, 2010

8:55 AM

Targacept Makes Strategic Additions to Inflammatory Disorders Program - Business Wire

Wed, Jul 28, 2010

8:55 AM

Targacept to Report Second Quarter 2010 Financial Results on August 4, 2010 - Business Wire

Wed, Jun 23, 2010

8:55 AM

AstraZeneca and Targacept Initiate Phase 3 Clinical Development of TC-5214 as an Adjunct Treatment for Major Depressive Disorder - Business Wire

Fri, Nov 13, 2009

8:02 PM

Semi-Annual Changes to the NASDAQ Biotechnology Index - Globe Newswire

Wed, Nov 04, 2009

12:34 PM

Depression Treatments Reviewed by NeuroInvestment - Marketwire

Thu, Jun 05, 2008

9:59 AM

Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin Lymphoma Data at International Conference on Malignant Lymphoma and Published Third Party, Independent Research Corroborates Promise of TAP Cancer Therapeutic as a Therapy for the Treatment of Cancer - Financial News USA

Thu, Dec 07, 2006

12:00 PM

Targacept, Inc. (TRGT) Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell - Globe Newswire

More News for TRGT >>

Tags for Targacept Inc.

Research stocks or mutual funds related to Targacept Inc. by keywords or tags. Find companies that have a similar focus to TRGT. The keywords below have been associated to TRGT by either user submission or electronic means.

biotechnology company biotech research pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment biotechnology market pharmaceutical research and development dupont pharmaceuticals pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license pfizer pharmaceutical company pharmaceutical cro biopharmaceutical companies pharma companies pharma consulting pharma consultants pharmaceutical distributors company patent biotech pharmaceutical company pharmaceutical development biopharmaceutical company pharmaceutical magazine pharmaceutical consultant Drugs pharmaceutical auctions pharma r&d pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical manufacturing pharma reports contract pharmaceutical pharmaceutical consulting pharmaceutical medical packaging news pharmaceutical industry biopharmaceutical market clinical trials europe acetylcholine patent research pharmaceutical advances pharmaceutical distributor pharmaceutical out licensing pharmaceutical business development Healthcare medical and pharmaceutical packaging pharmaceutical sector bio pharmaceuticals

Bookmark With:

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.